OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)
Study sponsor: Ocular Therapeutix, Inc. · OCUL
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-05-22Actual
Enrollment · participants100Actual
Source updated2024-07-10Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.